Evotec has announced the nomination of Wolfgang Hofmann to its supervisory board. This decision reflects the company's commitment to strengthening its governance and oversight functions. Hofmann's extensive experience in the pharmaceutical and biotechnology sectors is expected to contribute positively to the board's strategic direction. The nomination will be subject to approval at the upcoming shareholders' meeting.
Related Articles
Don't miss out on breaking stories and in-depth articles.